These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37092793)

  • 21. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
    Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
    Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence.
    Fontana AO; Piffaretti D; Marchi F; Burgio F; Faia-Torres AB; Paganetti P; Pinton S; Pieles U; Reinert M
    J Neurooncol; 2017 Jul; 133(3):497-507. PubMed ID: 28500562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells.
    Karmakar S; Banik NL; Patel SJ; Ray SK
    Neurosci Lett; 2007 Mar; 415(3):242-7. PubMed ID: 17335970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification.
    Rezaei S; Assaran Darban R; Javid H; Hashemy SI
    Biomed Res Int; 2022; 2022():8540403. PubMed ID: 35281606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme.
    Napier TS; Udayakumar N; Jani AH; Hartman YE; Houson HA; Moore L; Amm HM; van den Berg NS; Sorace AG; Warram JM
    Mol Cancer Ther; 2020 Sep; 19(9):1922-1929. PubMed ID: 32606015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines.
    Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H
    Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells.
    Dikmen M; Gökhaner G; Cantürk Z
    Anticancer Drugs; 2019 Aug; 30(7):e0769. PubMed ID: 31306152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma.
    Jeising S; Geerling G; Guthoff R; Hänggi D; Sabel M; Rapp M; Nickel AC
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103049. PubMed ID: 35932958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone enhances the effectiveness of 5-aminolevulinic acid-based photodynamic therapy for squamous cell carcinoma and glioblastoma in vitro.
    Shi L; Buchner A; Pohla H; Pongratz T; Rühm A; Zimmermann W; Gederaas OA; Zhang L; Wang X; Stepp H; Sroka R
    J Biophotonics; 2019 Oct; 12(10):e201800468. PubMed ID: 31140754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells.
    Lawrence JE; Steele CJ; Rovin RA; Belton RJ; Winn RJ
    J Neurooncol; 2016 Mar; 127(1):15-21. PubMed ID: 26643803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity.
    Doan P; Nguyen P; Murugesan A; Candeias NR; Yli-Harja O; Kandhavelu M
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.
    Albert I; Hefti M; Luginbuehl V
    Neurol Res; 2014 Nov; 36(11):1001-10. PubMed ID: 24923209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.
    Ju D; Yamaguchi F; Zhan G; Higuchi T; Asakura T; Morita A; Orimo H; Hu S
    Tumour Biol; 2016 Aug; 37(8):10415-26. PubMed ID: 26846106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
    Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S
    J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
    Robinson P; Coveñas R; Muñoz M
    Curr Med Chem; 2023; 30(16):1798-1812. PubMed ID: 35959620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug.
    Kast RE
    J Clin Pharm Ther; 2010 Dec; 35(6):657-63. PubMed ID: 21054456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme.
    Afshari AR; Motamed-Sanaye A; Sabri H; Soltani A; Karkon-Shayan S; Radvar S; Javid H; Mollazadeh H; Sathyapalan T; Sahebkar A
    Curr Med Chem; 2021; 28(24):4877-4892. PubMed ID: 33441062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV.
    Barrett JS; Spitsin S; Moorthy G; Barrett K; Baker K; Lackner A; Tulic F; Winters A; Evans DL; Douglas SD
    J Transl Med; 2016 May; 14(1):148. PubMed ID: 27230663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Shikonin in improving 5-aminolevulinic acid-based photodynamic therapy and chemotherapy on glioblastoma stem cells.
    Werner M; Lyu C; Stadlbauer B; Schrader I; Buchner A; Stepp H; Sroka R; Pohla H
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():102987. PubMed ID: 35760350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.